{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:25:38Z","timestamp":1772166338102,"version":"3.50.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["302\/21"],"award-info":[{"award-number":["302\/21"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["700\/16"],"award-info":[{"award-number":["700\/16"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001698","name":"Israel Cancer Research Fund","doi-asserted-by":"publisher","award":["17-1693-RCDA"],"award-info":[{"award-number":["17-1693-RCDA"]}],"id":[{"id":"10.13039\/100001698","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006221","name":"United States - Israel Binational Science Foundation","doi-asserted-by":"publisher","award":["2021055"],"award-info":[{"award-number":["2021055"]}],"id":[{"id":"10.13039\/100006221","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007225","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["DKFZ-MOST #001192"],"award-info":[{"award-number":["DKFZ-MOST #001192"]}],"id":[{"id":"10.13039\/100007225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003975","name":"Israel Cancer Association","doi-asserted-by":"crossref","award":["20220009"],"award-info":[{"award-number":["20220009"]}],"id":[{"id":"10.13039\/501100003975","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ovarian cancer (OC) is known for exhibiting low response rates to immune checkpoint inhibitors that activate T cells. However, immunotherapies that activate B cells have not yet been extensively explored and may be a potential target, as B cells that secrete immunoglobulins have been associated with better outcomes in OC. Although the secretion of immunoglobulins is often mediated by the microbiome, it is still unclear what role they play in limiting the progression of OC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted an in-vivo CRISPR screen of immunodeficient (NSG) and immune-intact wild type (WT) C57\/BL6 mice to identify tumor-derived immune-escape mechanisms in a BRAC1- and TP53-deficient murine ID8 OC cell line (designated ITB1). To confirm gene expression and signaling pathway activation in ITB1 cells, we employed western blot, qPCR, immunofluorescent staining, and flow cytometry. Flow cytometry was also used to identify immune cell populations in the peritoneum of ITB1-bearing mice. To determine the presence of IgA-coated bacteria in the peritoneum of ITB1-bearing mice and the ascites of OC patients, we employed 16S sequencing. Testing for differences was done by using Deseq2 test and two-way ANOVA test. Sequence variants (ASVs) were produced in Qiime2 and analyzed by microeco and phyloseq R packages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified tumor necrosis factor receptor-associated factor 3 (TRAF3) as a tumor-derived immune suppressive mediator in ITB1 cells. Knockout of TRAF3 (TRAF3KO) activated the type-I interferon pathway and increased MHC-I expression. TRAF3KO tumors exhibited a growth delay in WT mice vs. NSG mice, which was correlated with increased B cell infiltration and activation compared to ITB1 tumors. B cells were found to be involved in the progression of TRAF3KO tumors, and B-cell surface-bound and secreted IgA levels were significantly higher in the ascites of TRAF3KO tumors compared to ITB1. The presence of commensal microbiota was necessary for B-cell activation and for delaying the progression of TRAF3KO tumors in WT mice. Lastly, we observed unique profiles of IgA-coated bacteria in the ascites of OC-bearing mice or the ascites of OC patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TRAF3 is a tumor-derived immune-suppressive modulator that influences B-cell infiltration and activation, making it a potential target for enhancing anti-tumor B-cell responses in OC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-023-02680-7","type":"journal-article","created":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T22:02:13Z","timestamp":1682892133000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["TRAF3 suppression encourages B cell recruitment and prolongs survival of microbiome-intact mice with ovarian cancer"],"prefix":"10.1186","volume":"42","author":[{"given":"Jonathan","family":"Zorea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yair","family":"Motro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roei D.","family":"Mazor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifat Koren","family":"Carmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziv","family":"Shulman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamal","family":"Mahajna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Moran-Gilad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3634-9098","authenticated-orcid":false,"given":"Moshe","family":"Elkabets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,1]]},"reference":[{"key":"2680_CR1","unstructured":"Global Cancer Observatory, (n.d.). https:\/\/gco.iarc.fr\/#cancer-causes. (Accessed 23 Nov 2021)."},{"key":"2680_CR2","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1158\/2159-8290.CD-15-0714","volume":"5","author":"PA Konstantinopoulos","year":"2015","unstructured":"Konstantinopoulos PA, Ceccaldi R, Shapiro GI, D\u2019Andrea AD. Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer. Cancer Discov. 2015;5:1137\u201354. https:\/\/doi.org\/10.1158\/2159-8290.CD-15-0714.","journal-title":"Cancer Discov"},{"key":"2680_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29210","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015. https:\/\/doi.org\/10.1002\/ijc.29210.","journal-title":"Int J Cancer"},{"key":"2680_CR4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/DIAGNOSTICS10030146","volume":"10","author":"F Borella","year":"2020","unstructured":"Borella F, Ghisoni E, Giannone G, Cosma S, Benedetto C, Valabrega G, Katsaros D. Immune Checkpoint Inhibitors in Epithelial Ovarian Cancer: An Overview on Efficacy and Future Perspectives. Diagnostics. 2020;10:146. https:\/\/doi.org\/10.3390\/DIAGNOSTICS10030146.","journal-title":"Diagnostics."},{"key":"2680_CR5","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","volume":"33","author":"MA Postow","year":"2015","unstructured":"Postow MA, Callahan MK, Wolchok JD. Immune Checkpoint Blockade in Cancer Therapy. J Clin Oncol. 2015;33:1974. https:\/\/doi.org\/10.1200\/JCO.2014.59.4358.","journal-title":"J Clin Oncol"},{"key":"2680_CR6","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.1002\/CNCR.32520","volume":"125","author":"A Gonz\u00e1lez-Mart\u00edn","year":"2019","unstructured":"Gonz\u00e1lez-Mart\u00edn A, S\u00e1nchez-Lorenzo L. Immunotherapy with checkpoint inhibitors in patients with ovarian cancer: Still promising? Cancer. 2019;125:4616\u201322. https:\/\/doi.org\/10.1002\/CNCR.32520.","journal-title":"Cancer"},{"key":"2680_CR7","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.3389\/FONC.2020.604084","volume":"10","author":"F Ning","year":"2021","unstructured":"Ning F, Cole CB, Annunziata CM. Driving Immune Responses in the Ovarian Tumor Microenvironment. Front Oncol. 2021;10:3060. https:\/\/doi.org\/10.3389\/FONC.2020.604084.","journal-title":"Front Oncol"},{"key":"2680_CR8","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1007\/S13277-015-4538-0\/FIGURES\/6","volume":"37","author":"X Wei","year":"2016","unstructured":"Wei X, Jin Y, Tian Y, Zhang H, Wu J, Lu W, Lu X. Regulatory B cells contribute to the impaired antitumor immunity in ovarian cancer patients. Tumor Biol. 2016;37:6581\u20138. https:\/\/doi.org\/10.1007\/S13277-015-4538-0\/FIGURES\/6.","journal-title":"Tumor Biol"},{"key":"2680_CR9","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1158\/1078-0432.CCR-15-2762","volume":"22","author":"DR Kroeger","year":"2016","unstructured":"Kroeger DR, Milne K, Nelson BH. Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer. Clin Cancer Res. 2016;22:3005\u201315. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2762.","journal-title":"Clin Cancer Res"},{"key":"2680_CR10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0081","author":"A Montfort","year":"2017","unstructured":"Montfort A, Pearce O, Maniati E, Vincent BG, Bixby L, B\u00f6hm S, Dowe T, Wilkes EH, Chakravarty P, Thompson R, Topping J, Cutillas PR, Lockley M, Serody JS, Capasso M, Balkwill FR. A strong B-cell response is part of the immune landscape in human high-grade serous ovarian metastases. Clin Cancer Res. 2017. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0081.","journal-title":"Clin Cancer Res"},{"issue":"7850","key":"2680_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41586-020-03144-0","volume":"591","author":"S Biswas","year":"2021","unstructured":"Biswas S, Mandal G, Payne KK, Anadon CM, Gatenbee CD, Chaurio RA, Costich TL, Moran C, Harro CM, Rigolizzo KE, Mine JA, Trillo-Tinoco J, Sasamoto N, Terry KL, Marchion D, Buras A, Wenham RM, Yu X, Townsend MK, Tworoger SS, Rodriguez PC, Anderson AR, Conejo-Garcia JR. IgA transcytosis and antigen recognition govern ovarian cancer immunity. Nat. 2021;591(7850):464\u201370. https:\/\/doi.org\/10.1038\/s41586-020-03144-0.","journal-title":"Nat."},{"issue":"6","key":"2680_CR12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nri2322","volume":"8","author":"A Cerutti","year":"2008","unstructured":"Cerutti A. The regulation of IgA class switching. Nat Rev Immunol. 2008;8(6):421\u201334. https:\/\/doi.org\/10.1038\/nri2322.","journal-title":"Nat Rev Immunol."},{"key":"2680_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/IMR.12179","volume":"260","author":"E Slack","year":"2014","unstructured":"Slack E, Balmer ML, Macpherson AJ. B cells as a critical node in the microbiota\u2013host immune system network. Immunol Rev. 2014;260:50\u201366. https:\/\/doi.org\/10.1111\/IMR.12179.","journal-title":"Immunol Rev"},{"issue":"4","key":"2680_CR14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/bjc.2017.435","volume":"118","author":"JJ Goedert","year":"2018","unstructured":"Goedert JJ, Hua X, Bielecka A, Okayasu I, Milne GL, Jones GS, Fujiwara M, Sinha R, Wan Y, Xu X, Ravel J, Shi J, Palm NW, Feigelson HS. Postmenopausal breast cancer and oestrogen associations with the IgA-coated and IgA-noncoated faecal microbiota. Br J Cancer. 2018;118(4):471\u20139. https:\/\/doi.org\/10.1038\/bjc.2017.435.","journal-title":"Br J Cancer."},{"issue":"1","key":"2680_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-38031-2","volume":"9","author":"B Zhou","year":"2019","unstructured":"Zhou B, Sun C, Huang J, Xia M, Guo E, Li N, Lu H, Shan W, Wu Y, Li Y, Xu X, Weng D, Meng L, Hu J, Gao Q, Ma D, Chen G. The biodiversity Composition of Microbiome in Ovarian Carcinoma Patients. Sci Reports. 2019;9(1):1\u201311. https:\/\/doi.org\/10.1038\/s41598-018-38031-2.","journal-title":"Sci Reports."},{"key":"2680_CR16","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S1470-2045(19)30340-7","volume":"20","author":"NR Nen\u00e9","year":"2019","unstructured":"Nen\u00e9 NR, Reisel D, Leimbach A, Franchi D, Jones A, Evans I, Knapp S, Ryan A, Ghazali S, Timms JF, Paprotka T, Bj\u00f8rge L, Zikan M, Cibula D, Colombo N, Widschwendter M. Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study. Lancet Oncol. 2019;20:1171\u201382. https:\/\/doi.org\/10.1016\/S1470-2045(19)30340-7.","journal-title":"Lancet Oncol"},{"key":"2680_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17119-1","author":"JB Walton","year":"2017","unstructured":"Walton JB, Farquharson M, Mason S, Port J, Kruspig B, Dowson S, Stevenson D, Murphy D, Matzuk M, Kim J, Coffelt S, Blyth K, McNeish IA. CRISPR\/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity. Sci Rep. 2017. https:\/\/doi.org\/10.1038\/s41598-017-17119-1.","journal-title":"Sci Rep"},{"key":"2680_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/SCIENCE.1247005","volume":"343","author":"O Shalem","year":"2014","unstructured":"Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelsen TS, Heckl D, Ebert BL, Root DE, Doench JG, Zhang F. Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells. Science. 2014;343:84. https:\/\/doi.org\/10.1126\/SCIENCE.1247005.","journal-title":"Science"},{"key":"2680_CR19","unstructured":"Nuclear & Cytoplasmic Extract Protocol | Rockland, (n.d.). https:\/\/www.rockland.com\/resources\/nuclear-and-cytoplasmatic-extract-protocol\/. (Accessed 6 Sept 2022)."},{"key":"2680_CR20","doi-asserted-by":"publisher","first-page":"6041","DOI":"10.4049\/jimmunol.0900747","volume":"183","author":"J Ochoa-Rep\u00e1raz","year":"2009","unstructured":"Ochoa-Rep\u00e1raz J, Mielcarz DW, Ditrio LE, Burroughs AR, Foureau DM, Haque-Begum S, Kasper LH. Role of Gut Commensal Microflora in the Development of Experimental Autoimmune Encephalomyelitis. J Immunol. 2009;183:6041\u201350. https:\/\/doi.org\/10.4049\/jimmunol.0900747.","journal-title":"J Immunol"},{"key":"2680_CR21","doi-asserted-by":"publisher","DOI":"10.3791\/53939","author":"MN Anahtar","year":"2016","unstructured":"Anahtar MN, Bowman BA, Kwon DS. Efficient nucleic acid extraction and 16s rRNA gene sequencing for bacterial community characterization. J Vis Exp. 2016. https:\/\/doi.org\/10.3791\/53939.","journal-title":"J Vis Exp"},{"key":"2680_CR22","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/BIOINFORMATICS\/BTV617","volume":"32","author":"J Winter","year":"2016","unstructured":"Winter J, Breinig M, Heigwer F, Br\u00fcgemann D, Leible S, Pelz O, Zhan T, Boutros M. caRpools: an R package for exploratory data analysis and documentation of pooled CRISPR\/Cas9 screens. Bioinformatics. 2016;32:632\u20134. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTV617.","journal-title":"Bioinformatics"},{"key":"2680_CR23","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1039\/C5MB00663E","volume":"12","author":"G Yu","year":"2016","unstructured":"Yu G, He QY. ReactomePA: An R\/Bioconductor package for reactome pathway analysis and visualization. Mol Biosyst. 2016;12:477\u20139. https:\/\/doi.org\/10.1039\/C5MB00663E.","journal-title":"Mol Biosyst"},{"key":"2680_CR24","doi-asserted-by":"publisher","unstructured":"Holm JB, Humphrys MS, Robinson CK, Settles ML, Ott S, Fu L, et al. Ultrahigh-Throughput Multiplexing and Sequencing of >500-Base-Pair Amplicon Regions on the Illumina HiSeq 2500 Platform, MSystems. 2019;4. https:\/\/doi.org\/10.1128\/MSYSTEMS.00029-19\/SUPPL_FILE\/MSYSTEMS.00029-19-SF007.PDF.","DOI":"10.1128\/MSYSTEMS.00029-19\/SUPPL_FILE\/MSYSTEMS.00029-19-SF007.PDF"},{"key":"2680_CR25","unstructured":"Babraham Bioinformatics - FastQC A Quality Control tool for High Throughput Sequence Data, (n.d.). https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/. (Accessed 5 Jan 2023)."},{"key":"2680_CR26","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/BIOINFORMATICS\/BTW354","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels P, Magnusson M, Lundin S, K\u00e4ller M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics. 2016;32:3047\u20138. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTW354.","journal-title":"Bioinformatics"},{"key":"2680_CR27","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/BIOINFORMATICS\/BTY560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34:i884\u201390. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTY560.","journal-title":"Bioinformatics"},{"issue":"8","key":"2680_CR28","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(8):852\u20137. https:\/\/doi.org\/10.1038\/s41587-019-0209-9.","journal-title":"Nat Biotechnol."},{"key":"2680_CR29","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/NAR\/GKS1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, Peplies J, Gl\u00f6ckner FO. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41:D590\u20136. https:\/\/doi.org\/10.1093\/NAR\/GKS1219.","journal-title":"Nucleic Acids Res"},{"key":"2680_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S40168-018-0605-2\/FIGURES\/6","volume":"6","author":"NM Davis","year":"2018","unstructured":"Davis NM, Proctor DM, Holmes SP, Relman DA, Callahan BJ. Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data. Microbiome. 2018;6:1\u201314. https:\/\/doi.org\/10.1186\/S40168-018-0605-2\/FIGURES\/6.","journal-title":"Microbiome."},{"key":"2680_CR31","doi-asserted-by":"publisher","unstructured":"Liu Y, Elworth RAL, Jochum MD, Aagaard KM, Treangen TJ. De novo identification of microbial contaminants in low microbial biomass microbiomes with Squeegee, Nat. Commun. 2022 131. 13 (2022) 1\u201314. doi:https:\/\/doi.org\/10.1038\/s41467-022-34409-z.","DOI":"10.1038\/s41467-022-34409-z"},{"key":"2680_CR32","doi-asserted-by":"publisher","unstructured":"Liu C, Cui Y, Li X, Yao M. Microeco: An R package for data mining in microbial community ecology. FEMS Microbiol Ecol. 2021;97. https:\/\/doi.org\/10.1093\/FEMSEC\/FIAA255.","DOI":"10.1093\/FEMSEC\/FIAA255"},{"key":"2680_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061217","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie PJ, Holmes S. Phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data. PLoS ONE. 2013. https:\/\/doi.org\/10.1371\/journal.pone.0061217.","journal-title":"PLoS ONE"},{"key":"2680_CR34","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1126\/science.aao1710","volume":"359","author":"D Pan","year":"2018","unstructured":"Pan D, Kobayashi A, Jiang P, De Andrade LF, Tay RE, Luoma AM, Tsoucas D, Qiu X, Lim K, Rao P, Long HW, Yuan GC, Doench J, Brown M, Liu XS, Wucherpfennig KW. A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing. Science (80-). 2018;359:770\u20135. https:\/\/doi.org\/10.1126\/science.aao1710.","journal-title":"Science (80-.)."},{"key":"2680_CR35","doi-asserted-by":"publisher","unstructured":"Gu SS, Zhang W, Wang X, Jiang P, Traugh N, Li Z, et al. Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade. Cancer Discov. 2021. https:\/\/doi.org\/10.1158\/2159-8290.cd-20-0812.","DOI":"10.1158\/2159-8290.cd-20-0812"},{"key":"2680_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/nri2998","author":"H H\u00e4cker","year":"2011","unstructured":"H\u00e4cker H, Tseng PH, Karin M. Expanding TRAF function: TRAF3 as a tri-faced immune regulator. Nat Rev Immunol. 2011. https:\/\/doi.org\/10.1038\/nri2998.","journal-title":"Nat Rev Immunol"},{"key":"2680_CR37","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/J.IMMUNI.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T, Lafontaine L, Berger A, Bruneval P, Fridman WH, Becker C, Pag\u00e8s F, Speicher MR, Trajanoski Z, Galon J\u00d4. Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer. Immunity. 2013;39:782\u201395. https:\/\/doi.org\/10.1016\/J.IMMUNI.2013.10.003.","journal-title":"Immunity"},{"key":"2680_CR38","unstructured":"[The primary structure of a monoclonal IgA-immunoglobulin (IgA Tro.), II. The amino acid sequence of the H-chain, alpha-type, subgroup III; structure of the complete IgA-molecule (author\u2019s transl)] - PubMed, (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/809331\/. (Accessed 26 Jan 2023)."},{"issue":"6","key":"2680_CR39","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","volume":"30","author":"D Zheng","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020;30(6):492\u2013506. https:\/\/doi.org\/10.1038\/s41422-020-0332-7.","journal-title":"Cell Res."},{"key":"2680_CR40","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.3390\/IJMS22094846","volume":"22","author":"M Bot\u00eda-S\u00e1nchez","year":"2021","unstructured":"Bot\u00eda-S\u00e1nchez M, Alarc\u00f3n-Riquelme ME, Galicia G. B Cells and Microbiota in Autoimmunity. Int J Mol Sci. 2021;22:4846. https:\/\/doi.org\/10.3390\/IJMS22094846.","journal-title":"Int J Mol Sci."},{"key":"2680_CR41","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1007\/S00262-021-03135-8\/FIGURES\/5","volume":"71","author":"A Noble","year":"2022","unstructured":"Noble A, Pring ET, Durant L, Man R, Dilke SM, Hoyles L, James SA, Carding SR, Jenkins JT, Knight SC. Altered immunity to microbiota, B cell activation and depleted \u03b3\u03b4\/resident memory T cells in colorectal cancer. Cancer Immunol Immunother. 2022;71:2619\u201329. https:\/\/doi.org\/10.1007\/S00262-021-03135-8\/FIGURES\/5.","journal-title":"Cancer Immunol Immunother"},{"key":"2680_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1084\/JEM.128.1.97","volume":"128","author":"DC Savage","year":"1968","unstructured":"Savage DC, Dubos R. Alterations in the mouse cecum and its flora produced by antibacterial drugs. J Exp Med. 1968;128:97\u2013110. https:\/\/doi.org\/10.1084\/JEM.128.1.97.","journal-title":"J Exp Med"},{"key":"2680_CR43","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/MPS3010018","volume":"3","author":"O Gabay","year":"2020","unstructured":"Gabay O, Vicenty J, Smith D, Tiffany L, Ascher J, Curry T, Dennis J, Clouse KA. Using a Model of Germ-Free Animals to Study the Impact of Gut Microbiome in Research: A Step by Step Sterility Setting and Management. Methods Protoc. 2020;3:18. https:\/\/doi.org\/10.3390\/MPS3010018.","journal-title":"Methods Protoc."},{"key":"2680_CR44","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/J.CELL.2014.08.006","volume":"158","author":"NW Palm","year":"2014","unstructured":"Palm NW, De Zoete MR, Cullen TW, Barry NA, Stefanowski J, Hao L, Degnan PH, Hu J, Peter I, Zhang W, Ruggiero E, Cho JH, Goodman AL, Flavell RA. Immunoglobulin A Coating Identifies Colitogenic Bacteria in Inflammatory Bowel Disease. Cell. 2014;158:1000\u201310. https:\/\/doi.org\/10.1016\/J.CELL.2014.08.006.","journal-title":"Cell"},{"issue":"7800","key":"2680_CR45","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41586-020-2095-1","volume":"579","author":"GD Poore","year":"2020","unstructured":"Poore GD, Kopylova E, Zhu Q, Carpenter C, Fraraccio S, Wandro S, Kosciolek T, Janssen S, Metcalf J, Song SJ, Kanbar J, Miller-Montgomery S, Heaton R, Mckay R, Patel SP, Swafford AD, Knight R. Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nat. 2020;579(7800):567\u201374. https:\/\/doi.org\/10.1038\/s41586-020-2095-1.","journal-title":"Nat."},{"key":"2680_CR46","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.3389\/FIMMU.2018.02111\/BIBTEX","volume":"9","author":"S Zhu","year":"2018","unstructured":"Zhu S, Jin J, Gokhale S, Lu AM, Shan H, Feng J, Xie P. Genetic alterations of TRAF proteins in human cancers. Front Immunol. 2018;9:2111. https:\/\/doi.org\/10.3389\/FIMMU.2018.02111\/BIBTEX.","journal-title":"Front Immunol"},{"key":"2680_CR47","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.1158\/0008-5472.CAN-17-0642\/652787\/AM\/ATTENUATED-TRAF3-FOSTERS-ALTERNATIVE-ACTIVATION-OF","volume":"78","author":"J Zhang","year":"2018","unstructured":"Zhang J, Chen T, Yang X, Cheng H, Spath SS, Clavijo PE, Chen J, Silvin C, Issaeva N, Su X, Yarbrough WG, Annunziata CM, Chen Z, Van Waes C. Attenuated TRAF3 fosters activation of alternative NF-kB and reduced expression of antiviral interferon, TP53, and RB to promote HPV-positive head and neck cancers. Cancer Res. 2018;78:4613\u201326. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0642\/652787\/AM\/ATTENUATED-TRAF3-FOSTERS-ALTERNATIVE-ACTIVATION-OF.","journal-title":"Cancer Res"},{"key":"2680_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13578-018-0268-5\/TABLES\/2","volume":"9","author":"X Xie","year":"2019","unstructured":"Xie X, Jin J, Zhu L, Jie Z, Li Y, Zhao B, Cheng X, Li P, Sun SC. Cell type-specific function of TRAF2 and TRAF3 in regulating type i IFN induction 11 Medical and Health Sciences 1107 Immunology. Cell Biosci. 2019;9:1\u201310. https:\/\/doi.org\/10.1186\/S13578-018-0268-5\/TABLES\/2.","journal-title":"Cell Biosci"},{"key":"2680_CR49","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/J.TRECAN.2021.12.003","volume":"8","author":"MATM van Vugt","year":"2022","unstructured":"van Vugt MATM, Parkes EE. When breaks get hot: inflammatory signaling in BRCA1\/2-mutant cancers. Trends in Cancer. 2022;8:174\u201389. https:\/\/doi.org\/10.1016\/J.TRECAN.2021.12.003.","journal-title":"Trends in Cancer"},{"key":"2680_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S00018-022-04219-Z\/TABLES\/4","volume":"79","author":"R Yu","year":"2022","unstructured":"Yu R, Zhu B, Chen D. Type I interferon-mediated tumor immunity and its role in immunotherapy. Cell Mol Life Sci. 2022;79:1\u201324. https:\/\/doi.org\/10.1007\/S00018-022-04219-Z\/TABLES\/4.","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"2680_CR51","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrc.2016.14","volume":"16","author":"BS Parker","year":"2016","unstructured":"Parker BS, Rautela J, Hertzog PJ. Antitumour actions of interferons: implications for cancer therapy. Nat Rev Cancer. 2016;16(3):131\u201344. https:\/\/doi.org\/10.1038\/nrc.2016.14.","journal-title":"Nat. Rev. Cancer."},{"key":"2680_CR52","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.3390\/CANCERS14092220","volume":"14","author":"D Schweer","year":"2022","unstructured":"Schweer D, McAtee A, Neupane K, Richards C, Ueland F, Kolesar J. Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy. Cancers. 2022;14:2220. https:\/\/doi.org\/10.3390\/CANCERS14092220.","journal-title":"Cancers."},{"key":"2680_CR53","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/J.YGYNO.2016.07.105","volume":"143","author":"PP Santoiemma","year":"2016","unstructured":"Santoiemma PP, Reyes C, Wang LP, McLane MW, Feldman MD, Tanyi JL, Powell DJ. Systematic evaluation of multiple immune markers reveals prognostic factors in ovarian cancer. Gynecol Oncol. 2016;143:120\u20137. https:\/\/doi.org\/10.1016\/J.YGYNO.2016.07.105.","journal-title":"Gynecol Oncol"},{"key":"2680_CR54","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1158\/1078-0432.CCR-16-0081\/116046\/AM\/A-STRONG-B-CELL-RESPONSE-IS-PART-OF-THE-IMMUNE","volume":"23","author":"A Montfort","year":"2017","unstructured":"Montfort A, Pearce O, Maniati E, Vincent BG, Bixby L, B\u00f6hm S, Dowe T, Wilkes EH, Chakravarty P, Thompson R, Topping J, Cutillas PR, Lockley M, Serody JS, Capasso M, Balkwill FR. A strong B-cell response is part of the immune landscape in human high-grade serous ovarian metastases. Clin Cancer Res. 2017;23:250\u201362. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0081\/116046\/AM\/A-STRONG-B-CELL-RESPONSE-IS-PART-OF-THE-IMMUNE.","journal-title":"Clin Cancer Res"},{"key":"2680_CR55","doi-asserted-by":"publisher","unstructured":"Montfort A, Pearce O, Maniati E, Vincent BG, Bixby L, B\u20ac Ohm S, Dowe T, Wilkes E.H, Chakravarty P, Thompson R, Topping J, Cutillas PR, Lockley M, Serody JS, Capasso M, Balkwill FR. Biology of Human Tumors A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases. Clin Cancer Res. 2017;23. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0081.","DOI":"10.1158\/1078-0432.CCR-16-0081"},{"key":"2680_CR56","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/JLB.1MR0321-660R","volume":"110","author":"B Yu","year":"2021","unstructured":"Yu B, Wang L, Chu Y. Gut microbiota shape B cell in health and disease settings. J Leukoc Biol. 2021;110:271\u201381. https:\/\/doi.org\/10.1002\/JLB.1MR0321-660R.","journal-title":"J Leukoc Biol"},{"key":"2680_CR57","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.it.2016.10.003","volume":"37","author":"BA Heesters","year":"2016","unstructured":"Heesters BA, Van Der Poel CE, Das A, Carroll MC. Antigen Presentation to B Cells. Trends Immunol. 2016;37:844\u201354. https:\/\/doi.org\/10.1016\/j.it.2016.10.003.","journal-title":"Trends Immunol"},{"issue":"11","key":"2680_CR58","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41575-019-0209-8","volume":"16","author":"SH Wong","year":"2019","unstructured":"Wong SH, Yu J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat Rev Gastroenterol Hepatol. 2019;16(11):690\u2013704. https:\/\/doi.org\/10.1038\/s41575-019-0209-8.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"1","key":"2680_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-27555-x","volume":"13","author":"AE Asangba","year":"2023","unstructured":"Asangba AE, Chen J, Goergen KM, Larson MC, Oberg AL, Casarin J, Multinu F, Kaufmann SH, Mariani A, Chia N, Walther-Antonio MRS. Diagnostic and prognostic potential of the microbiome in ovarian cancer treatment response. Sci Reports. 2023;13(1):1\u201318. https:\/\/doi.org\/10.1038\/s41598-023-27555-x.","journal-title":"Sci. Reports."},{"key":"2680_CR60","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.1158\/0008-5472.CAN-22-0455","volume":"82","author":"LM Chambers","year":"2022","unstructured":"Chambers LM, Esakov Rhoades EL, Bharti R, Braley C, Tewari S, Trestan L, et al. Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer. Cancer Res. 2022;82:4654\u201369. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-0455.","journal-title":"Cancer Res."},{"key":"2680_CR61","doi-asserted-by":"publisher","unstructured":"Enomoto H, Inoue SI, Matsuhisa A, Nishiguchi S. Diagnosis of Spontaneous Bacterial Peritonitis and an In Situ Hybridization Approach to Detect an \u201cUnidentified\u201d Pathogen. Int J Hepatol. 2014;(2014). https:\/\/doi.org\/10.1155\/2014\/634617.","DOI":"10.1155\/2014\/634617"},{"key":"2680_CR62","doi-asserted-by":"publisher","unstructured":"Lee SR, Lee JC, Kim SH, Oh YS, Chae HD, Seo H, Kang CS, Shin TS. Altered Composition of Microbiota in Women with Ovarian Endometrioma: Microbiome Analyses of Extracellular Vesicles in the Peritoneal Fluid. Int J Mol Sci. 2021;22. https:\/\/doi.org\/10.3390\/IJMS22094608.","DOI":"10.3390\/IJMS22094608"},{"key":"2680_CR63","doi-asserted-by":"publisher","unstructured":"Menard J, Goggs R, Mitchell P, Yang Y, Robbins S, Franklin-Guild RJ, Thachil AJ, Altier C, Anderson R, Putzel GG, McQueary H, Goodman LB. Effect of antimicrobial administration on fecal microbiota of critically ill dogs: dynamics of antimicrobial resistance over time. Anim Microbiome. 2022;4. https:\/\/doi.org\/10.1186\/S42523-022-00178-9.","DOI":"10.1186\/S42523-022-00178-9"},{"key":"2680_CR64","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1126\/SCIENCE.AAX0701\/SUPPL_FILE\/AAX0701_FLUCKIGER_SM.PDF","volume":"369","author":"A Fluckiger","year":"2020","unstructured":"Fluckiger A, Daill\u00e8re R, Sassi M, Sixt BS, Liu P, Loos F, Richard C, Rabu C, Alou MT, Goubet AG, Lemaitre F, Ferrere G, Derosa L, Duong CPM, Messaoudene M, Gagn\u00e9 A, Joubert P, de Sordi L, Debarbieux L, Simon S, Scarlata CM, Ayyoub M, Palermo B, Facciolo F, Boidot R, Wheeler R, Boneca IG, Sztupinszki Z, Papp K, Csabai I, Pasolli E, Segata N, Lopez-Otin C, Szallasi Z, Andre F, Iebba V, Quiniou V, Klatzmann D, Boukhalil J, Khelaifia S, Raoult D, Albiges L, Escudier B, Eggermont A, Mami-Chouaib F, Nistico P, Ghiringhelli F, Routy B, Labarri\u00e8re N, Cattoir V, Kroemer G, Zitvogel L. Cross-reactivity between tumor MHC class I\u2013restricted antigens and an enterococcal bacteriophage. Science. 2020;369:936\u201342. https:\/\/doi.org\/10.1126\/SCIENCE.AAX0701\/SUPPL_FILE\/AAX0701_FLUCKIGER_SM.PDF.","journal-title":"Science."},{"key":"2680_CR65","doi-asserted-by":"publisher","first-page":"5933","DOI":"10.4049\/JIMMUNOL.1401702","volume":"193","author":"CA White","year":"2014","unstructured":"White CA, Pone EJ, Lam T, Tat C, Hayama KL, Li G, Zan H, Casali P. Histone Deacetylase Inhibitors Upregulate B Cell microRNAs That Silence AID and Blimp-1 Expression for Epigenetic Modulation of Antibody and Autoantibody Responses. J Immunol. 2014;193:5933\u201350. https:\/\/doi.org\/10.4049\/JIMMUNOL.1401702.","journal-title":"J Immunol"},{"key":"2680_CR66","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1126\/SCIENCE.1240527\/SUPPL_FILE\/IIDA.SM.PDF","volume":"342","author":"N Iida","year":"2013","unstructured":"Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, Molina DA, Salcedo R, Back T, Cramer S, Dai RM, Kiu H, Cardone M, Naik S, Patri AK, Wang E, Marincola FM, Frank KM, Belkaid Y, Trinchieri G, Goldszmid RS. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science (80-). 2013;342:967\u201370. https:\/\/doi.org\/10.1126\/SCIENCE.1240527\/SUPPL_FILE\/IIDA.SM.PDF.","journal-title":"Science (80-.)."},{"key":"2680_CR67","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/SCIENCE.ABF3363\/SUPPL_FILE\/ABF3363_MDAR_REPRODUCIBILITY_CHECKLIST.PDF","volume":"371","author":"D Davar","year":"2021","unstructured":"Davar D, Dzutsev AK, McCulloch JA, Rodrigues RR, Chauvin JM, Morrison RM, Deblasio RN, Menna C, Ding Q, Pagliano O, Zidi B, Zhang S, Badger JH, Vetizou M, Cole AM, Fernandes MR, Prescott S, Costa RGF, Balaji AK, Morgun A, Vujkovic-Cvijin I, Wang H, Borhani AA, Schwartz MB, Dubner HM, Ernst SJ, Rose A, Najjar YG, Belkaid Y, Kirkwood JM, Trinchieri G, Zarour HM. Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients. Science (80-). 2021;371:595\u2013602. https:\/\/doi.org\/10.1126\/SCIENCE.ABF3363\/SUPPL_FILE\/ABF3363_MDAR_REPRODUCIBILITY_CHECKLIST.PDF.","journal-title":"Science (80-.)."}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-023-02680-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-023-02680-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-023-02680-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T22:02:51Z","timestamp":1682892171000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-023-02680-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,1]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2680"],"URL":"https:\/\/doi.org\/10.1186\/s13046-023-02680-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2555950\/v1","asserted-by":"object"}]},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,1]]},"assertion":[{"value":"7 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments were conducted in compliance with protocols established by the Institutional Animal Care and Use Committee (IACUC) of Ben-Gurion University of the Negev for ensuring animal welfare and minimizing discomfort. The animal ethical clearance protocol number used for the study was IL-23\u201305-2020(E).The acquisition and analysis of human ascites samples was approved by the ethics in research committee of the Rabin Medical Center and Ziv Medical Center under protocol 0450\u201316-RMC and 201913481, respectively. Informed consent was obtained from all participants prior to their recruitment to the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have no potential conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}